Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced the appointment of Dr. David Feygin as Managing Director and Head of Digital Health, SaaS and AI. Dr. Feygin joins Outcome Capital in a full-time leadership role to expand its strategic advisory and investment banking capabilities as artificial intelligence and digital technologies create new opportunities for innovation and value creation across life sciences and healthcare.

Advances in AI, particularly agentic AI, are challenging traditional software business models, moving toward more customized and outcome-driven solutions. As these technologies evolve, companies and investors must increasingly assess implications for competitive positioning, investment strategies and long-term growth. Outcome Capital has been examining the financial implications of this transformation, including how agentic AI is influencing healthcare software valuations and driving M&A and investment activity. With this new digital technology environment, companies are increasingly pursuing acquisitions, partnerships and other transactions to access novel capabilities and strengthen their edge over competitors.

“Organic development alone can’t keep pace with AI. As startups prove their models, enterprise acquisitions will accelerate, and Health AI companies that show even early commercial scalability will command unprecedented multiples, because AI has become existential for every incumbent,” said Dr. Feygin. “I’ve worked on both sides of this, leading digital and AI strategy inside a global MedTech leader and building AI companies from the ground up. At Outcome, I’ll use that experience to help founders show buyers that their business model can scale and their AI can be trusted, and to help acquirers tell real innovation apart from hype, so that AI innovation turns into transactions that create lasting value.”

“AI and digital health are converging rapidly, fundamentally changing the competitive landscape for companies. This change requires a deep understanding of emerging trends, clinical and regulatory dynamics, and investor and enterprise priorities,” said Dr. Oded Ben-Joseph, Managing Partner at Outcome Capital. “With David leading this practice, we’re better positioned to help clients anticipate market changes for strategic opportunities.”

In his role, Dr. Feygin will lead Outcome Capital’s Digital Health, SaaS and AI practice. He will advise both emerging and established companies, investors and other industry stakeholders on strategic transactions and opportunities. His work will draw on the firm’s integrated model that leverages scientific, clinical, operational and financial expertise. “AI represents a once-in-a-generation shift in how value is created and captured across the industry. One of the most important questions facing healthcare companies today is whether to build, buy or partner to capitalize on the next-generation of digital health platforms,” said Dr. Feygin. “Outcome Capital brings these perspectives together to help clients make informed decisions in an emerging AI-driven economy.”

About Outcome Capital

Outcome Capital is a highly specialized life sciences and healthcare advisory and investment banking firm providing innovative companies with a value-added, market-aligned approach to mergers and acquisitions, partnering and corporate finance. The firm leverages its strategy-led execution model to help management teams, boards and investors navigate financial and corporate markets and implement the optimal path for success. Outcome Capital’s team includes former CEOs, operating executives, venture capitalists, scientists, clinicians and commercialization leaders, all focused on driving successful outcomes across the healthcare ecosystem.

Media gallery

About The Author
Business Wire